MRK Stock Trading Above 200- & 50-Day SMA for 2 Months: Time to Buy?

Key Takeaways Merck has traded above its 50- and 200-day SMAs since early November, signaling sustained momentum.Pipeline progress and acquisitions, including Cidara and Verona, should support Merck's long-term growth.Weak Gardasil demand in China and Keytruda's 2028 LOE raise concerns despite strong launches like Capvaxive.Merck’s (MRK) stock has been trading above its 50-day and 200-day simple moving averages (SMAs) since early November, indicating sustained bullish momentum.The 50-day moving average is a ...